MedicarePartD.guide

A non-government resource built from CMS public data

CDK4/6 inhibitors for breast cancer on every 2026 Illinois Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Illinois cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

CDK4/6 inhibitors for breast cancer by 2026 Illinois Part D plan
DrugWellcare Classic$0.00/moS4802-087Wellcare Value Script$0.00/moS4802-151Humana Basic Rx Plan$0.00/moS5884-107Humana Value Rx Plan$0.00/moS5884-196AARP Medicare Rx Saver from UHC$40.20/moS5921-362HealthSpring Extra Rx$66.60/moS5617-367Blue Cross MedicareRx Basic$89.70/moS5715-012SilverScript Choice$94.90/moS5601-034AARP Medicare Rx Preferred from UHC$103.90/moS5921-398HealthSpring Assurance Rx$104.20/moS5617-224Humana Premier Rx Plan$119.40/moS5884-163Blue Cross MedicareRx Value$119.70/moS5715-001
IbrancepalbociclibTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA26%QL 21/28dTier 5PA25%QL 21/21dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA31%QL 21/21dTier 5PA25%QL 21/28dTier 5PA33%QL 21/28dTier 5PA25%QL 21/28d
KisqaliribociclibTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA26%QL 21/28dTier 5PA25%QL 21/21dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%Tier 5PA31%QL 21/21dTier 5PA25%QL 21/28dTier 5PA33%QL 21/28dTier 5PA25%QL 21/28d
VerzenioabemaciclibTier 5PA25%QL 56/28dTier 5PA25%QL 56/28dTier 5PA25%QL 60/30dTier 5PA26%QL 60/30dTier 5PA25%QL 56/28dTier 5PA25%QL 60/30dTier 5PA25%QL 60/30dTier 5PA25%Tier 5PA31%QL 56/28dTier 5PA25%QL 60/30dTier 5PA33%QL 60/30dTier 5PA25%QL 60/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.